Trial Profile
Maintenance Treatment With Capecitabine Plus Cetuximab After First-line 5-Fluorouracil-based Chemotherapy Plus Cetuximab for Patients With RAS Wild-type Metastatic Colorectal Cancer: a Single Arm, Open-label, Multi-center Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Jan 2017 Results (n=13) assessing efficacy and safety of MT-CAP plus CET, presented at the 2017 Gastrointestinal Cancers Symposium
- 30 Mar 2016 New trial record